Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1 1

Status

Recruiting 4Not yet recruiting 4Active not recruiting 4Terminated 3Completed 3Unknown 2Withdrawn 1

Sponsor Class

OTHER 3NIH 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Thoracic 4

Conditions

Carcinoma, Non-Small-Cell Lung 4Endometrial Neoplasms 3Stomach Neoplasms 2Lymphoma, Large B-Cell, Diffuse 2Lung Neoplasms 2Carcinoma, Hepatocellular 2Uterine Cervical Neoplasms 1Thrombophilia 1Thrombocytopenia 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Cancer Extensive Stage 1Salivary Gland Neoplasms 1Pathologic Complete Response 1Papillomavirus Infections 1Pancreatitis, Chronic 1Pancreatic Neoplasms 1Oropharyngeal Neoplasms 1Neoplasms 1Myelosuppression 1Myeloproliferative Disorders 1Mouth Neoplasms 1Lymphoma, Non-Hodgkin 1Leukopenia 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leiomyoma 1Immunoglobulin G4-Related Disease 1Hypersplenism 1Hemoglobinuria, Paroxysmal 1Hematologic Diseases 1Growth Hormone-Secreting Pituitary Adenoma 1

Interventions

Carboplatin 31Pemetrexed 26Drug Therapy 22Cisplatin 21osimertinib 18aflutinib 10Surgical Procedures, Operative 10Paclitaxel 10Docetaxel 10tislelizumab 9pembrolizumab 8anlotinib 7Specimen Handling 7Magnetic Resonance Spectroscopy 7Bevacizumab 7toripalimab 6durvalumab 6cemiplimab 6Immunotherapy 6130-nm albumin-bound paclitaxel 6sintilimab 5ensartinib 5Radiotherapy 5Platinum Compounds 5Nivolumab 5trametinib 4aumolertinib 4Observation 4Cetuximab 4Blood Specimen Collection 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Not yet recruiting × Carcinoma, Non-Small-Cell Lung × Observation × Clear all
NCT07596524 2026-05-19

Analysis of Different Second Line Treatment in Advanced NSCLC Patients Progressing After 1st Line Immune Checkpoint Inhibitor Therapy

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Not yet recruiting
300 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07388524 2026-05-13

Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial

National Cancer Institute (NCI)

Phase 3 Not yet recruiting
336 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT06743555 2026-04-28

SAVED LUNG

Centre hospitalier de l'Université de Montréal (CHUM)

Phase 1 Not yet recruiting
14 enrolled
Thoracic

Pathologic Complete Response, Carcinoma, Non-Small-Cell Lung

NCT07472478 2026-03-16

GIVEN

Guangdong Provincial People's Hospital

Phase 2 Not yet recruiting
32 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡